SOLANA SOL PRICE PREDICTION 2025
2 extracted signals · 2 resolved · 0 still active
Cilinix Crypto04 Nov 2025, 15:43 UTC
AI-generated source summary
The analysis focuses on Solana (SOL) against both USDT and BTC. Since October 10th, SOLUSDT has shifted downwards. After breaking 181, a steeper decline was expected. The next support level is around 144.29, which aligns with the older fair value gaps. A reclaim of $200 was needed to remain bullish. For SOLBTC, its one of the weakest BTC pairs. The pair has shifted back into a range it was in before, indicating it could drop lower. The analyst suggests that there is a significant indication that Solana is expected to underperform against Bitcoin. If SOLBTC broke below, one could start considering short positions at the $128 support. The analysis concludes with a bearish outlook for SOLUSDT, anticipating a potential retest upwards to fill imbalances before a further decline.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Cilinix Crypto
BREAKDOWN UPDATE: WILL CRYPTO CRASH LOWER?🚨
DON'T MISS THIS MAJOR BULLISH SIGNAL!🔥 (Polkadot Update)
HEDERA PRICE PREDICTION FOR AUGUST! (HBAR Update)
SOLANA BREAKDOWN WARNING NOW!🚨 (SOL Update)
I AM WAITING FOR THIS ETHEREUM MOVE! (ETH Update)
CRITICAL MOMENT FOR XRP! (Breakdown Risk)
Cilinix Crypto
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

